These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28197641)

  • 1. Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway.
    Park SH; Chung YJ; Song JY; Kim SI; Pépin D; MacLaughlin DT; Donahoe PK; Kim JH
    Int J Oncol; 2017 Mar; 50(3):1022-1028. PubMed ID: 28197641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional profiles of Müllerian inhibiting substance/anti-Müllerian hormone (MIS/AMH) in primarily cultured endometrial cancer cells.
    Kim SI; Yoon JH; Hur SY
    J Cancer; 2021; 12(20):6289-6300. PubMed ID: 34539902
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of Müllerian-Inhibiting Substance/Anti-Müllerian Hormone Type II Receptor in the Human Theca Cells.
    Cheon KY; Chung YJ; Cho HH; Kim MR; Cha JH; Kang CS; Lee JY; Kim JH
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3376-3385. PubMed ID: 29947765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
    Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
    Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
    Chauvin M; Garambois V; Choblet S; Colombo PE; Chentouf M; Gros L; De Brauwere DP; Duonor-Cerutti M; Dumas K; Robert B; Jarlier M; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis.
    Chung YJ; Kim HJ; Park SH; Yoon JH; Kim MR; Nam SW; MacLaughlin DT; Donahoe PK; Kim JH
    Int J Oncol; 2015 May; 46(5):2039-46. PubMed ID: 25760378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.
    Hwang SJ; Suh MJ; Yoon JH; Kim MR; Ryu KS; Nam SW; Donahoe PK; Maclaughlin DT; Kim JH
    Int J Oncol; 2011 Oct; 39(4):811-20. PubMed ID: 21573503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.
    Zhang K; Zhu S; Liu Y; Dong X; Shi Z; Zhang A; Liu C; Chen L; Wei J; Pu P; Zhang J; Jiang T; Han L; Kang C
    Cancer Lett; 2015 Feb; 357(1):404-411. PubMed ID: 25434796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells.
    Chauvin M; Garambois V; Colombo PE; Chentouf M; Gros L; Brouillet JP; Robert B; Jarlier M; Dumas K; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
    Sci Rep; 2021 Jan; 11(1):2231. PubMed ID: 33500516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
    Wu Z; Zheng S; Li Z; Tan J; Yu Q
    Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria.
    Kim SM; Kim YO; Lee MK; Chung YJ; Jeung IC; Kim MR; Kim JH
    Oncol Lett; 2019 Jan; 17(1):532-538. PubMed ID: 30655798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines.
    Jung YS; Kim HJ; Seo SK; Choi YS; Nam EJ; Kim S; Kim SW; Han HD; Kim JW; Kim YT
    Yonsei Med J; 2016 Jan; 57(1):33-40. PubMed ID: 26632380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
    Wang C; Wang J; Liu H; Fu Z
    Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
    Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
    Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.
    Sogutlu F; Kayabasi C; Ozmen Yelken B; Asik A; Gasimli R; Dogan F; Yilmaz Süslüer S; Biray Avcı C; Gunduz C
    J Cell Biochem; 2019 Jan; 120(1):380-395. PubMed ID: 30145828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.